Follow
Jim X. Leng
Jim X. Leng
Duke University Medical Center
Verified email at duke.edu
Title
Cited by
Cited by
Year
Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas
OA Zill, C Greene, D Sebisanovic, LM Siew, J Leng, M Vu, AE Hendifar, ...
Cancer discovery 5 (10), 1040-1048, 2015
280*2015
Inhibiting histone deacetylase as a means to reverse resistance to angiogenesis inhibitors: phase I study of abexinostat plus pazopanib in advanced solid tumor malignancies
R Aggarwal, S Thomas, N Pawlowska, I Bartelink, J Grabowsky, T Jahan, ...
Journal of Clinical Oncology 35 (11), 1231, 2017
882017
Differential toxicity in patients with and without DNA repair mutations: phase I study of carboplatin and talazoparib in advanced solid tumors
MS Dhawan, IH Bartelink, RR Aggarwal, J Leng, JZ Zhang, N Pawlowska, ...
Clinical Cancer Research 23 (21), 6400-6410, 2017
622017
Infrastructural challenges lead to delay of curative radiotherapy in Nigeria
J Leng, AI Ntekim, A Ibraheem, CP Anakwenze, DW Golden, OI Olopade
JCO global oncology 6, 269-276, 2020
272020
Safety and efficacy of hypofractionated radiotherapy with capecitabine in elderly patients with urothelial carcinoma
J Leng, AS Akthar, RZ Szmulewitz, PH O’Donnell, RF Sweis, SP Pitroda, ...
Clinical genitourinary cancer 17 (1), e12-e18, 2019
92019
Emerging use of public-private partnerships in public radiotherapy facilities in Nigeria
CP Anakwenze Akinfenwa, A Ibraheem, K Nwankwo, N Lasebikan, ...
JCO Global Oncology 7, 1260-1269, 2021
82021
Wikipedia: a medical student educational project to edit Wikipedia in preparation for practicing evidence-based pain medicine
D Kantarovich, HB Vollbrecht, SA Cruz, H Castillo, CS Lee, J Kushner, ...
Journal of Medical Education and Curricular Development 7, 2382120520959691, 2020
62020
A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.
MS Dhawan, IH Bartelink, RR Aggarwal, J Leng, RK Kelley, ME Melisko, ...
Journal of Clinical Oncology 35 (15_suppl), 2527-2527, 2017
52017
Efficacy and hematologic toxicity of carboplatin and talazoparib combination therapy in BRCA mutated patients.
MS Dhawan, RR Aggarwal, I Bartelink, J Leng, S Thomas, N Pawlowska, ...
Journal of Clinical Oncology 34 (15_suppl), 2557-2557, 2016
52016
Hematuria following post-prostatectomy radiotherapy: incidence increases with long-term followup
WT Turchan, D Cutright, T Wu, JX Leng, JJ Dignam, SE Eggener, ...
The Journal of Urology 207 (6), 1236-1245, 2022
42022
Evaluating the Reliability of Chat-GPT Model Responses for Radiation Oncology Patient Inquiries
W Floyd, T Kleber, M Pasli, JJ Qazi, CC Huang, JX Leng, B Ackerson, ...
International Journal of Radiation Oncology, Biology, Physics 117 (2), e383, 2023
32023
Current Strengths and Weaknesses of ChatGPT as a Resource for Radiation Oncology Patients and Providers
W Floyd, T Kleber, DJ Carpenter, M Pasli, J Qazi, C Huang, J Leng, ...
International Journal of Radiation Oncology* Biology* Physics 118 (4), 905-915, 2024
22024
Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases
DJ Carpenter, J Leng, M Arshad, W Giles, JP Kirkpatrick, SR Floyd, ...
JAMA network open 6 (4), e2310117-e2310117, 2023
22023
Survey of medical student knowledge in oncology and survivorship care in Nigeria: A pilot study.
J Leng, AF Ibraheem, AI Ntekim, A Popoola, L Agaga, E Ukoh, ...
Journal of Clinical Oncology 37 (15_suppl), e18106-e18106, 2019
22019
Comparison of public-private partnership and federally sponsored radiotherapy facilities in Nigeria
CP Anakwenze, S Grover, A Ibraheem, AH Klopp, A Jhingran, LL Lin, ...
International Journal of Radiation Oncology, Biology, Physics 108 (3), e413-e414, 2020
12020
Attitudes of breast cancer patients and oncology staff towards randomized clinical trials in southwest Nigeria.
J Leng, AF Ibraheem, AC Sowunmi, AF Ademola, A Ntekim, OI Olopade
Journal of Clinical Oncology 36 (15_suppl), e18663-e18663, 2018
12018
Early, molecular detection of cancer utilizing circulating cell-free DNA assay with ultra high accuracy and sensitivity.
S Mortimer, K Dilger, D Abdueva, D Chudova, A Sarin, CE Atreya, J Leng, ...
Journal of Clinical Oncology 34 (15_suppl), 11540-11540, 2016
12016
Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
RR Aggarwal, S Thomas, JA Grabowsky, A Harb, J Leng, A Reinert, ...
Journal of Clinical Oncology 34 (15_suppl), 2519-2519, 2016
12016
Determinants of symptomatic intracranial progression following an initial stereotactic radiosurgery course
JX Leng, DJ Carpenter, C Huang, J Qazi, M Arshad, TC Mullikin, ...
Advances in Radiation Oncology, 101475, 2024
2024
Clinical Outcomes Following an Initial Stereotactic Radiosurgery Course for Brain Metastases from Melanoma
JX Leng, CC Huang, JJ Qazi, DJ Carpenter, BD Natarajan, M Arshad, ...
International Journal of Radiation Oncology, Biology, Physics 117 (2), e128, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20